Alnylam Pharmaceuticals Posts Q2 Adjusted EPS $1.84
Alnylam beats Q2 adjusted EPS estimate
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Alnylam beats Q2 adjusted EPS estimate
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.